Raymond Benza

Cereno Scientific's CS014 attracts interest within the medical community

Cereno Scientific's drug portfolio continues to attract attention within the medical community, this time with the preclinical drug candidate CS014, a...

Cereno Scientific strengthens its R&D organization

Swedish biotechnology company Cereno Scientific has appointed Fredrik Frick...

Cereno Scientific faces an eventful 2022

2021 brought significant progress for Cereno Scientific. The company...

Intervju

Cereno Scientific contributes expertise to CVCT Forum

In parallel with Cereno Scientific preparing the start of...

Intervju

Cereno Scientific receives SEK 95,3 million

Cereno Scientific recently achieved an important milestone when...

Cereno Scientific receives IND approval for Phase II initiation

The FDA has approved Cereno Scientific's IND application for the company's...

Intervju

Cereno Scientific in collaboration with Abbott 

Swedish biopharmaceutical company Cereno Scientific has taken another...